Articles by Jeff Fetterman - Pharmaceutical Executive


Articles by Jeff Fetterman

Jeff Fetterman

Seeing Around Corners: Risk Assessment Is the Foundation of Risk-Based Monitoring
June 5, 2014

There is an expectation and early evidence that risk-based monitoring can produce significant improvements in trial quality and productivity. In this paper, inVentiv Health outlines a systematic and rigorous process to assessing risk, using quality risk management principles that will increase the likelihood that your RBM approach will pass regulators’ scrutiny.

Rx Risk-Management: Making the Case for FMEA
August 30, 2013

Learn why FMEA, or Failure Mode and Effects Analysis, should be the standard methodology used in pharmaceutical risk-management and how it can reduce the patient's risk at each step of the medication use process.


Click here